Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1950 4
1952 1
1953 2
1954 1
1960 1
1964 3
1965 4
1966 2
1967 3
1968 3
1969 2
1970 3
1971 2
1972 1
1973 5
1974 8
1975 10
1976 6
1977 11
1978 11
1979 10
1980 20
1981 17
1982 14
1983 17
1984 24
1985 25
1986 17
1987 26
1988 23
1989 37
1990 35
1991 26
1992 39
1993 36
1994 41
1995 41
1996 43
1997 48
1998 70
1999 53
2000 74
2001 71
2002 68
2003 77
2004 98
2005 90
2006 98
2007 91
2008 87
2009 111
2010 89
2011 101
2012 117
2013 111
2014 118
2015 123
2016 113
2017 102
2018 119
2019 112
2020 129
2021 146
2022 101
2023 124
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

2,933 results

Results by year

Filters applied: . Clear all
Page 1
Etiology and Outcomes of Thrombotic Microangiopathies.
Bayer G, von Tokarski F, Thoreau B, Bauvois A, Barbet C, Cloarec S, Mérieau E, Lachot S, Garot D, Bernard L, Gyan E, Perrotin F, Pouplard C, Maillot F, Gatault P, Sautenet B, Rusch E, Buchler M, Vigneau C, Fakhouri F, Halimi JM. Bayer G, et al. Clin J Am Soc Nephrol. 2019 Apr 5;14(4):557-566. doi: 10.2215/CJN.11470918. Epub 2019 Mar 12. Clin J Am Soc Nephrol. 2019. PMID: 30862697 Free PMC article.
Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study.
Scully M, de la Rubia J, Pavenski K, Metjian A, Knöbl P, Peyvandi F, Cataland S, Coppo P, Kremer Hovinga JA, Minkue Mi Edou J, De Passos Sousa R, Callewaert F, Gunawardena S, Lin J. Scully M, et al. J Thromb Haemost. 2022 Dec;20(12):2810-2822. doi: 10.1111/jth.15892. Epub 2022 Oct 21. J Thromb Haemost. 2022. PMID: 36138517 Free PMC article. Clinical Trial.
Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry.
Mansouri Taleghani M, von Krogh AS, Fujimura Y, George JN, Hrachovinová I, Knöbl PN, Quist-Paulsen P, Schneppenheim R, Lämmle B, Kremer Hovinga JA. Mansouri Taleghani M, et al. Hamostaseologie. 2013 May 29;33(2):138-43. doi: 10.5482/HAMO-13-04-0026. Hamostaseologie. 2013. PMID: 23715103 Review.
Post-varicella thrombocytopenic purpura.
Amir A, Gilad O, Yacobovich J, Scheuerman O, Tamary H, Garty BZ. Amir A, et al. Acta Paediatr. 2010 Sep;99(9):1385-8. doi: 10.1111/j.1651-2227.2010.01842.x. Acta Paediatr. 2010. PMID: 20456262
AIMS: The aim of the study was to characterize the clinical course of post-varicella idiopathic thrombocytopenic purpura (ITP) and to asses the risk of acquiring ITP after varicella infection. ...The average minimal platelet count was 9.5 109 platelets/L. Post-varicella IT …
AIMS: The aim of the study was to characterize the clinical course of post-varicella idiopathic thrombocytopenic purpura (ITP) and to …
Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management.
Mantadakis E, Farmaki E, Buchanan GR. Mantadakis E, et al. J Pediatr. 2010 Apr;156(4):623-8. doi: 10.1016/j.jpeds.2009.10.015. Epub 2010 Jan 25. J Pediatr. 2010. PMID: 20097358 Review.
OBJECTIVE: To determine the incidence of immune thrombocytopenic purpura (ITP) after measles-mumps-rubella (MMR) immunization compared with natural measles and rubella, its clinical course and outcome, and the risk of recurrence after repeat MMR vaccination. ...
OBJECTIVE: To determine the incidence of immune thrombocytopenic purpura (ITP) after measles-mumps-rubella (MMR) immunization compared with …
Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
Rogers KA, Woyach JA. Rogers KA, et al. Semin Oncol. 2016 Apr;43(2):300-10. doi: 10.1053/j.seminoncol.2016.02.011. Epub 2016 Feb 8. Semin Oncol. 2016. PMID: 27040709 Review.
Diagnosis of autoimmune cytopenias can be challenging as it is difficult to differentiate between autoimmunity and bone marrow failure due to disease progression. There is a need to distinguish these causes, as prognosis and treatment are not the same. Evidence regarding t …
Diagnosis of autoimmune cytopenias can be challenging as it is difficult to differentiate between autoimmunity and bone marrow failure due t …
2,933 results